Immunomodulatory effects of growth hormone administration are associated with improvement in myocardial contractile performance in dilated cardiomyopathy patients

被引：0
作者：
Adamopoulos, S
Parissis, JT
Paraskevaidis, J
Karatzas, D
Kroupis, C
Livanis, E
Karavolias, G
Kremastinos, DT
机构：
[1] Onassis Cardiac Surg Ctr, Athens, Greece
[2] Amalia Fleming Hosp, Athens, Greece
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2003年 / 41卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：265A / 265A
页数：1
相关论文
共 50 条
[21]   The clinical parameters associated with improvement of ventricular function in patients with dilated cardiomyopathy [J].
Huang, Tsuci Yuan ;
Ku, Por Ming ;
Huang, Tsung-Ping .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 122 :90-90
[22]   IMPROVEMENT IN EXERCISE PERFORMANCE AND HEMODYNAMICS BY LABETALOL IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY [J].
LEUNG, WH ;
LAU, CP ;
WONG, CK ;
CHENG, CH ;
TAI, YT ;
LIM, SP .
AMERICAN HEART JOURNAL, 1990, 119 (04) :884-890
[23]   Effects of growth hormone on circulating cytokine dysbalance and left ventricular geometry in patients with idiopathic dilated cardiomyopathy [J].
Adamopoulos, S ;
Parissis, JT ;
Karatzas, D ;
Paraskevaidis, J ;
Karavolias, G ;
Degiannis, D ;
Kremastinos, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) :473A-473A
[24]   Anti-apoptotic effects of growth hormone are associated with reverse cardiac remodelling in patients with heart failure secondary to idiopathic dilated cardiomyopathy [J].
Adamopoulos, S ;
Parissis, JT ;
Karatzas, D ;
Paraskevaidis, I ;
Livanis, E ;
Karavolias, G ;
Degiannis, D ;
Kremastinos, D .
EUROPEAN HEART JOURNAL, 2004, 25 :183-183
[25]   Growth hormone-induced reduction of soluble apoptosis mediators is associated with reverse cardiac remodelling and improvement of exercise capacity in patients with idiopathic dilated cardiomyopathy [J].
Parissis, JT ;
Adamopoulos, S ;
Karatzas, D ;
Paraskevaidis, J ;
Livanis, E ;
Kremastinos, C .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2005, 12 (02) :164-168
[26]   Myocardial contractile reserve as prognostic determinant in patients with idiopathic dilated cardiomyopathy without overt heart failure [J].
Nagaoka, H ;
Isobe, N ;
Kubota, S ;
Iizuka, T ;
Imai, S ;
Suzuki, T ;
Nagai, R .
CHEST, 1997, 111 (02) :344-350
[27]   Myocardial gene expression in peripheral blood of patients with idiopathic dilated cardiomyopathy is associated with myocardial function [J].
Kontaraki, J. E. ;
Patrianakos, A. P. ;
Parthenakis, F. I. ;
Nyktari, E. G. ;
Vardas, P. E. .
EUROPEAN HEART JOURNAL, 2009, 30 :445-445
[28]   MYOCARDIAL FIBROSIS IS COMMON IN PATIENTS WITH DILATED CARDIOMYOPATHY AND IS ASSOCIATED WITH POOR QUALITY OF LIFE [J].
Khan, R. ;
Massel, D. ;
White, J. A. .
CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 :96D-96D
[29]   Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy [J].
Razi Khan ;
David Massel ;
David Scholl ;
John Stiratt ;
Gerald Wisenberg ;
R Terry Thompson ;
Frank Prato ;
Derek Boughner ;
Maria Drangova ;
James A White .
Journal of Cardiovascular Magnetic Resonance, 13 (Suppl 1)
[30]   Relationship between myocardial 123I-MIBG findings and myocardial contractile reserve in patients with mild to moderate dilated cardiomyopathy [J].
Ohshima, S ;
Isobe, S ;
Izawa, H ;
Yamada, K ;
Ando, A ;
Kato, K ;
Nagata, K ;
Murohara, T ;
Yokota, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) :262A-262A
12345